Science Talk

When Sue Vincent learned in 2010 that her ovarian cancer had spread to three different parts of her body and was inoperable, she resigned herself to having only months to live. But then she was offered a place on a clinical trial for a pioneering drug called olaparib, the discovery and development of which was underpinned by our research. 12 years on, Sue is still taking olaparib, and explains how the work of our scientists has given her a quality of life she could only have dreamed about.

While Terry Fox is a household name in Canada, his story may be new to some people in the UK. In this blog, our Digital Communications Officer Laura-Maria Horga shares the story of the Canadian hero whose legacy continues more than 40 years after his death.

Dr Barbara Pittam, Registrar and Director of Academic Services at The Institute of Cancer Research, London, celebrates the achievements of our students in the month they gathered to receive their degrees in person for the first time since the Covid-19 pandemic.